share_log
Benzinga ·  Jun 27 00:46
Tempus AI Shares Are Trading Higher After the Company Announced It Received U.S. FDA 510(k) Clearance for Tempus ECG-AF Device That Uses AI to Help Identify Patients Who May Be at Increased Risk of Atrial Fibrillation/flutter
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment